HIV 자가 검사 키트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The HIV Self-Test Kits Market size is expected to reach USD 1551.17 Million in 2034 from USD 358.65 Million (2025) growing at a CAGR of 17.67% during 2026-2034.

The HIV self-test kits market is set for growth as healthcare systems and consumers embrace rapid, private, and accessible diagnostic solutions. Future kits will integrate microfluidics, biosensors, and AI-assisted interpretation algorithms to enhance accuracy, reliability, and user-friendliness. Connectivity with mobile apps and telemedicine platforms will enable real-time guidance, reporting, and linkage to care.

Emerging innovations include multiplexed kits for simultaneous detection of co-infections, simplified sampling methods, and enhanced sensitivity detection. Integration with predictive analytics and cloud-based health monitoring platforms will improve population-level screening, early diagnosis, and epidemiological tracking. Sustainable packaging and eco-friendly reagents will support environmental and regulatory compliance.

Future growth will be driven by public health initiatives, awareness campaigns, and the need for convenient, accessible testing solutions. By combining advanced diagnostics, AI-assisted interpretation, and digital health integration, HIV self-test kits will enhance early detection, patient autonomy, and global disease management efforts.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Lateral Flow Immunoassay
• Immunofiltration
• Fluorescent Chromatography

By Specimen Type

• Blood
• Oral Fluid
• Urine

By Test Generation

• Second Generation
• Third Generation

COMPANIES PROFILED

• OraSure Technologies, Inc, Chembio Diagnostic Systems, Atomo Diagnostics, BioSure UK, Biosynex Group, bioLytical Laboratories Inc, Orange Life, Bedfordbiotech, Sedia Biosciences Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIV SELF-TEST KITS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Lateral Flow Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunofiltration Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fluorescent Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIV SELF-TEST KITS MARKET: BY SPECIMEN TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Specimen Type
• 5.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oral Fluid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIV SELF-TEST KITS MARKET: BY TEST GENERATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Generation
• 6.2. Second Generation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Third Generation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIV SELF-TEST KITS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Specimen Type
  • 7.2.3 By Test Generation
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Specimen Type
  • 7.3.3 By Test Generation
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Specimen Type
  • 7.4.3 By Test Generation
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Specimen Type
  • 7.5.3 By Test Generation
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Specimen Type
  • 7.6.3 By Test Generation
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIV SELF-TEST KITS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 OraSure TechnologiesInc
  • 9.2.2 Chembio Diagnostic Systems
  • 9.2.3 Atomo Diagnostics
  • 9.2.4 BioSure UK
  • 9.2.5 Biosynex Group
  • 9.2.6 BioLytical Laboratories Inc
  • 9.2.7 Orange Life
  • 9.2.8 Bedfordbiotech
  • 9.2.9 Sedia Biosciences Corporation